IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available ...
These promising results—from an NIH-funded study that exclusively evaluated Masimo SET ® in a vulnerable, clinically fragile ...
Where (and how) you wear your health tracker can impact your data accuracy. Here's what researchers say matters most.
A Previously Banned Apple Watch Health Feature Is Now Here to Stay ...
CMF today launched its third smartwatch—the CMF Watch Pro 3. The smartwatch is a major upgrade to the Watch Pro 2 that was launched in 2024, bringing a brighter screen, improved heart rate, sleep ...
This condition’s prevalence is rising worldwide, and it is very treatable, but disparities in access to care remain.
One particularly problematic sleep disorder is sleep apnea, and it is not rare. The condition affects nearly 1 billion people ...
Oximetry has evolved from basic transmissive pulse oximetry used at the bedside to a spectrum of techniques tailored for diverse clinical settings. Conventional pulse oximeters estimate peripheral ...
Edwards Lifesciences on April 23 reported that its largest business, transcatheter aortic valve replacement (TAVR), ...
Worldwide Medical Supply has announced its FingerbPulse Fingertip Pulse Oximeter, a blood oxygen monitor designed for ...
Worldwide Medical Supply announces the release of its Finger Pulse Oximeter, which provides instant SpO2 and pulse rate ...
Zacks Investment Research on MSN
Masimo SET shows accurate pulse oximetry in newborns of all skin tones
Masimo MASI recently reported findings from the NeoPODS study, a large prospective real-world evaluation of its SET pulse oximetry technology in critically ill newborns. The study demonstrated less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results